Cross John Harry III 4
4 · Sonnet BioTherapeutics Holdings, Inc. · Filed Feb 17, 2023
Insider Transaction Report
Form 4
Cross John Harry III
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2023-02-06$1.06/sh−1,960$2,078→ 23,927 total
Footnotes (1)
- [F1]Includes unvested restricted stock units.